Rare birds in North America: acute hepatitis C cohorts.
作者信息
Cox Andrea L, Page Kimberly, Bruneau Julie, Shoukry Naglaa H, Lauer Georg M, Kim Arthur Y, Rosen Hugo R, Radziewicz Hank, Grakoui Arash, Fierer Daniel S, Branch Andrea D, Kaplan David E, Chang Kyong-Mi
出版信息
Gastroenterology. 2009 Jan;136(1):26-31. doi: 10.1053/j.gastro.2008.11.049. Epub 2008 Dec 4.
Abstract
摘要
相似文献
1
Rare birds in North America: acute hepatitis C cohorts.
Gastroenterology. 2009 Jan;136(1):26-31. doi: 10.1053/j.gastro.2008.11.049. Epub 2008 Dec 4.
2
More rare birds, and the occasional swan.
Gastroenterology. 2009 Jun;136(7):2412-4. doi: 10.1053/j.gastro.2009.04.040. Epub 2009 May 3.
3
Influence of HTLV-2 infection on hepatitis C virus replication in HIV-positive patients.
J Clin Virol. 2005 Apr;32(4):338-9. doi: 10.1016/j.jcv.2004.08.013.
4
Serological status for HBV and HCV infection in anti-HIV seropositive and seronegative intravenous drug abusers.
Boll Soc Ital Biol Sper. 1991 Jan;67(1):103-8.
5
HIV & IV drug users and hepatitis "C".
Women Alive. 2000 Fall-Winter:9.
6
Treatment of acute C hepatitis in intravenous drug users.
J Hepatol. 2005 Jul;43(1):186-7. doi: 10.1016/j.jhep.2005.03.010. Epub 2005 Apr 26.
7
Cohort profile: the Canadian HIV-hepatitis C co-infection cohort study.
Int J Epidemiol. 2010 Oct;39(5):1162-9. doi: 10.1093/ije/dyp297. Epub 2009 Sep 28.
8
Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France.
Epidemiol Infect. 2004 Aug;132(4):699-708. doi: 10.1017/s095026880400247x.
9
[Modifications of epidemiological characteristics of hepatitis C].
Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B138-43.
10
Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.
Med J Aust. 2003 Jul 21;179(2):119; author reply 119.
引用本文的文献
1
Coordinated expansion of memory T follicular helper and B cells mediates spontaneous clearance of HCV reinfection.
Front Immunol. 2024 Jun 10;15:1403769. doi: 10.3389/fimmu.2024.1403769. eCollection 2024.
2
In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet?
World J Hepatol. 2021 Oct 27;13(10):1234-1268. doi: 10.4254/wjh.v13.i10.1234.
3
Where to Next? Research Directions after the First Hepatitis C Vaccine Efficacy Trial.
Viruses. 2021 Jul 13;13(7):1351. doi: 10.3390/v13071351.
4
Adaptive Immune Response against Hepatitis C Virus.
Int J Mol Sci. 2020 Aug 6;21(16):5644. doi: 10.3390/ijms21165644.
5
Challenges and Promise of a Hepatitis C Virus Vaccine.
Cold Spring Harb Perspect Med. 2020 Feb 3;10(2):a036947. doi: 10.1101/cshperspect.a036947.
6
Use of an Outbred Rat Hepacivirus Challenge Model for Design and Evaluation of Efficacy of Different Immunization Strategies for Hepatitis C Virus.
Hepatology. 2020 Mar;71(3):794-807. doi: 10.1002/hep.30894. Epub 2019 Oct 11.
7
Approaches, Progress, and Challenges to Hepatitis C Vaccine Development.
Gastroenterology. 2019 Jan;156(2):418-430. doi: 10.1053/j.gastro.2018.08.060. Epub 2018 Sep 27.
8
Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance.
PLoS Pathog. 2018 Sep 17;14(9):e1007290. doi: 10.1371/journal.ppat.1007290. eCollection 2018 Sep.
9
IFN-λ3 polymorphism indirectly influences NK cell phenotype and function during acute HCV infection.
Immun Inflamm Dis. 2016 Aug 16;4(3):376-88. doi: 10.1002/iid3.122. eCollection 2016 Sep.
10
Use of Hepatitis C Virus (HCV) Immunoglobulin G Antibody Avidity as a Biomarker to Estimate the Population-Level Incidence of HCV Infection.
J Infect Dis. 2016 Aug 1;214(3):344-52. doi: 10.1093/infdis/jiw005. Epub 2016 Jan 14.
本文引用的文献
1
High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.
J Immunol. 2008 Dec 15;181(12):8215-25. doi: 10.4049/jimmunol.181.12.8215.
2
Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoire.
J Immunol. 2008 Nov 1;181(9):6435-46. doi: 10.4049/jimmunol.181.9.6435.
3
Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+ memory T cells.
J Virol. 2008 Oct;82(20):10017-31. doi: 10.1128/JVI.01083-08. Epub 2008 Jul 30.
4
Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection.
J Virol. 2008 Oct;82(20):9808-22. doi: 10.1128/JVI.01075-08. Epub 2008 Jul 30.
5
Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study.
J Infect Dis. 2008 Sep 1;198(5):683-6. doi: 10.1086/590430.
6
Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.
Gastroenterology. 2008 Jun;134(7):1927-37, 1937.e1-2. doi: 10.1053/j.gastro.2008.02.033. Epub 2008 Feb 17.
7
Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis.
J Hepatol. 2008 Jun;48(6):903-13. doi: 10.1016/j.jhep.2008.01.030. Epub 2008 Mar 7.
8
Defining the directionality and quality of influenza virus-specific CD8+ T cell cross-reactivity in individuals infected with hepatitis C virus.
J Clin Invest. 2008 Mar;118(3):1143-53. doi: 10.1172/JCI33082.
9
CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiation.
Hepatology. 2008 Feb;47(2):396-406. doi: 10.1002/hep.22040.
10
Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infection.
J Infect Dis. 2008 Jan 1;197(1):46-57. doi: 10.1086/523651.
Zotero 插件